Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 4 2Phase 2 2Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Endometrial Neoplasms 3Obesity 2Endometrial Hyperplasia 2Weight Loss 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Opioid-Related Disorders 1Lymphoma, Follicular 1Hyperplasia 1Breast Neoplasms 1

Interventions

Vitamin D 2Tirzepatide 2Metformin 2licogliflozin 1indole-3-carbinol 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Tablets 1Specimen Handling 1Resistance Training 1Progestins 1Pregabalin 1Orlistat 1Organizational Objectives 1Omeprazole 1Observation 1Naltrexone 1Ketorolac 1Exergaming 1Exercise 1Exenatide 1Diet, Plant-Based 1Dexmedetomidine 1Dalteparin 1Counseling 1Cholecalciferol 1Calcium Citrate 1Calcium Carbonate 1Calcitriol 1CKD732 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Obesity × Tirzepatide × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07228741 2026-06-04

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

St. Jude Children's Research Hospital

Phase 2 Recruiting
20 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡